PROTAGONIST THERAPEUTICS INC's ticker is PTGX and the CUSIP is 74366E102. A total of 190 filers reported holding PROTAGONIST THERAPEUTICS INC in Q2 2024. The put-call ratio across all filers is 5.26 and the average weighting 0.4%.
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Johnson & Johnson Innovation - JJDC, Inc. | 2,449,183 | $43,253,000 | 8.50% |
BVF INC/IL | 2,367,288 | $41,806,000 | 2.58% |
RTW INVESTMENTS, LP | 3,383,208 | $59,747,000 | 1.68% |
Novo Holdings A/S | 824,169 | $14,555,000 | 0.94% |
DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 1,013,495 | $17,898,000 | 0.52% |
Sofinnova Investments, Inc. | 326,064 | $5,758,000 | 0.36% |
FARALLON CAPITAL MANAGEMENT LLC | 2,500,000 | $44,150,000 | 0.35% |
Virtus ETF Advisers LLC | 21,639 | $382,000 | 0.18% |
Baker Brothers Advisors | 1,911,446 | $33,756,000 | 0.15% |
King Wealth Management Group | 22,000 | $389,000 | 0.11% |